Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Fracture Surgery
- Sponsor
- Peking University First Hospital
- Study ID
- NCT07643792
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Fascia Iliaca Block
- Hip Fracture Surgery
- Liposomal Bupivacaine
- Older Adults
- Postoperative Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Liposomal bupivacaine (LB) — DRUGA single preoperative ultrasound-guided supra-inguinal fascia iliaca block will be perfomed using a mixture of 10 mL of 0.5% plain bupivacaine plus 20 mL of liposomal bupivacaine (266 mg), total volume 30 mL. The injection will be performed after negative aspiration and under real-time ultrasound visualization to ensure proper spread between the fascia iliaca and the iliacus muscle. The block will be performed in the preoperative holding area.
- Plain bupivacaine — DRUGA single preoperative ultrasound-guided supra-inguinal fascia iliaca block will be performed using 30 mL of 0.5% plain bupivacaine (150 mg). The injection will be performed after negative aspiration and under real-time ultrasound visualization to ensure proper spread between the fascia iliaca and the iliacus muscle. The block will be performed in the preoperative holding area.
Study Details
Older patients with hip fractures often suffer from severe pain. Inadequate analgesia increases the risk of postoperative delirium, myocardial injury, and other complications. Peripheral nerve block is an important component of multimodal analgesia, but conventional local anesthetics (such as plain bupivacaine) provide only approximately 12 hours of analgesic duration, which is far from covering the most painful 72 hours after surgery. Liposomal bupivacaine has a slow-release property, prolonging the analgesic duration up to 72 hours after a single injection. However, its clinical advantages in hip fracture surgery remain controversial. The investigators suppose that, compared with plain bupivacaine alone, preoperative supra-inguinal fascia iliaca block using liposomal bupivacaine combined with plain bupivacaine can further improve analgesia, decrease opioid consumption, and improve postoperative recovery quality within 72 hours in older patients after hip fracture surgery.
Key Dates
- First listed
- Jun 12, 2026
- Start date
- Jul 31, 2026
- Status verified
- Jun 2026
- Primary completion
- Jun 30, 2028
- Completion
- Aug 31, 2028
Study Design
- Enrollment
- 148 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Liposomal bupivacaine groupParticipants in this arm will receive a single preoperative ultrasound-guided supra-inguinal fascia iliaca block. The mixture used for nerve block will consist of 10 mL of 0.5% plain bupivacaine plus 20 mL of liposomal bupivacaine (266 mg), for a total volume of 30 mL. The mixture will be injected after negative aspiration and under real-time ultrasound visualization to confirm correct needle tip position between the fascia iliaca and the iliacus muscle. The block will be performed in the preoperative holding area.
- Active Comparator: Plain bupivacaine groupParticipants in this arm will receive a single preoperative ultrasound-guided supra-inguinal fascia iliaca block. The mixture used for nerve block will consist of 30 mL of 0.5% plain bupivacaine (total 150 mg). The mixture will be injected after negative aspiration and under real-time ultrasound visualization to confirm correct needle tip position between the fascia iliaca and the iliacus muscle. The block will be performed in the preoperative holding area.
Primary Outcome Measure
The area under curve of pain intensity within 72 hours after surgery [ Time Frame: Up to 72 hours after the surgery ]
Central Contacts
- Dong-Xin Wang, MD, PhD010-83572784
- Zhen Zhang, MD+86 13681035526
Related Studies
- Influenza Immunization in Adults Over Age 75Recruiting · Johns Hopkins University · Baltimore, Maryland
- Ketamine in Patients Undergoing TEVAR Procedures Receiving NCIPHASE2 · Recruiting · Sam Tyagi · Lexington, Kentucky
- Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic SurgeryRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce PainPHASE3 · Recruiting · University of California, San Francisco · San Francisco, California